New Steroidal Glycosides Isolated As CD40L Inhibitors of Activated Platelets

Haifeng Chen,Wenchao Ou,Guanghui Wang,Naili Wang,Linnan Zhang,Xinsheng Yao
DOI: https://doi.org/10.3390/molecules15074589
2010-01-01
Abstract:Three new compounds were isolated from the dried bulbs of Allium macrostemon Bunge. Their structures were elucidated from their spectral data as (25R)-26-O-beta-D-glucopyranosyl-5 alpha-furostane-3 beta, 12 beta,22,26-tetraol-3-O-beta-D-glucopyranosyl (1 -> 2) [beta-D-glucopyranosyl (1 -> 3)]-beta-D-glucopyranosyl (1 -> 4)-beta-D-galactopyranoside (1), (25R)-26-O-beta-D-glucopyranosyl-5 alpha-furostane-3 beta, 12 alpha,22,26-tetraol-3-O-beta-D-gluco-pyranosyl (1 -> 2) [beta-D-glucopyranosyl (1 -> 3)]-beta-D-glucopyranosyl (1 -> 4)-beta-D-galacto-pyranoside (2) and (25R)-26-O-beta-D-glucopyranosyl-5 beta-furostane-3 beta, 12 alpha,22,26-tetraol-3-O-beta-D-glucopyranosyl (1 -> 2)-beta-D-galactopyranoside (3), respectively. The inhibition effect of all compounds on CD40 ligand (CD40L) expression on the membrane of activated platelets stimulated by ADP was tested. Compounds 1 and 2 exhibited significant inhibitory activities in a dose dependent manner (P < 0.05), suggesting their potential application as CD40L inhibitors.
What problem does this paper attempt to address?